Your mother has been coughing for three weeks. She has lost weight, wakes up drenched in sweat, and the neighbourhood doctor casually says, "Get a sputum test done — could be TB." Suddenly your world tilts. Tuberculosis feels like a disease from another era, yet India reports roughly 27 lakh new cases every year — the highest burden of any country on earth. The good news? TB is completely curable, treatment is available free of cost at government facilities, and India's National Tuberculosis Elimination Programme (NTEP) has made enormous strides in diagnosis, treatment, and patient support.
This guide walks you through everything an Indian patient or caregiver needs to know — from recognising symptoms and getting the right tests to understanding your treatment regimen, accessing free government support, and tracking your recovery.
What Is Tuberculosis (TB)?
Tuberculosis (TB) is a bacterial infection caused by Mycobacterium tuberculosis. It spreads through tiny droplets when a person with active pulmonary TB coughs, sneezes, or speaks. TB most commonly attacks the lungs (pulmonary TB), but it can affect virtually any organ — lymph nodes, spine, brain, kidneys, or abdomen (extrapulmonary TB).
Latent TB vs Active TB
Not everyone infected with TB bacteria falls sick. Understanding this distinction is critical:
| Feature | Latent TB Infection (LTBI) | Active TB Disease |
|---|---|---|
| Symptoms | None | Cough >2 weeks, fever, weight loss, night sweats |
| Contagious? | No | Yes (pulmonary TB) |
| Chest X-ray | Usually normal | Abnormal (cavities, infiltrates) |
| Sputum test | Negative | Positive (in pulmonary TB) |
| Treatment needed? | Yes — preventive therapy recommended | Yes — full anti-TB treatment mandatory |
| Progression risk | 5-10% lifetime risk (higher if immunocompromised) | Already active — untreated TB is fatal in ~50% of cases |
About 40% of the Indian population carries latent TB infection according to ICMR estimates. Of these, 5-10% will develop active TB in their lifetime — a risk that jumps dramatically in people with diabetes, HIV, malnutrition, or those on immunosuppressive therapy.
Recognising TB Symptoms Early
Early detection saves lives and prevents transmission. Consult a doctor if you or a family member has any combination of these symptoms:
Pulmonary TB (Lungs)
- Persistent cough lasting more than 2 weeks — this is the cardinal symptom and the trigger for TB testing under NTEP
- Coughing up blood or blood-streaked sputum (haemoptysis)
- Chest pain or breathlessness
- Evening rise of temperature / low-grade fever
- Drenching night sweats
- Unexplained weight loss (>5% in the last 3 months)
- Loss of appetite and fatigue
Extrapulmonary TB
In India, 15-24% of TB cases are extrapulmonary. Common forms include:
- Lymph node TB (TB lymphadenitis): Painless, firm swelling in the neck — the most common extrapulmonary form in India
- Spinal TB (Pott's spine): Back pain, stiffness, sometimes neurological symptoms
- TB meningitis: Headache, fever, neck stiffness, confusion — a medical emergency
- Abdominal TB: Chronic abdominal pain, bloating, weight loss
- Pleural TB: Fluid around the lungs causing breathlessness
- Genitourinary TB: Affects kidneys, bladder, or reproductive organs
Important: Extrapulmonary TB is generally not contagious (since bacteria are not expelled through coughing), but it still requires full treatment.
How TB Is Diagnosed in India
India has significantly upgraded its diagnostic capabilities under NTEP. Here are the key tests your doctor may order:
First-Line Diagnostic Tests
| Test | What It Does | Time for Results | Cost (Govt.) | Cost (Private) |
|---|---|---|---|---|
| Sputum Smear Microscopy | Detects TB bacteria under microscope | 1-2 hours | Free | ₹100-300 |
| CB-NAAT / GeneXpert | Molecular test detecting TB + rifampicin resistance | 2 hours | Free at NTEP centres | ₹2,000-4,000 |
| Chest X-ray | Images lung abnormalities | 30 minutes | Free at govt. hospitals | ₹200-500 |
| Sputum Culture (MGIT) | Gold standard — grows TB bacteria | 2-8 weeks | Free at NTEP labs | ₹1,000-2,500 |
Additional Tests
| Test | Purpose | Cost (Private) |
|---|---|---|
| Mantoux / Tuberculin Skin Test (TST) | Screens for TB infection (latent or active) | ₹200-500 |
| IGRA (QuantiFERON-TB Gold) | Blood test for TB infection — more specific than Mantoux | ₹2,500-4,000 |
| Drug Susceptibility Testing (DST) | Checks if TB bacteria are resistant to specific drugs | Free under NTEP |
| Line Probe Assay (LPA) | Rapid detection of drug resistance | Free under NTEP |
| CT Scan / MRI | For extrapulmonary TB diagnosis | ₹3,000-10,000 |
The NTEP Diagnostic Pathway
Under NTEP, the recommended diagnostic approach for any patient with presumptive TB is:
- Upfront CB-NAAT (GeneXpert) — now the preferred first test, replacing sputum microscopy as the initial diagnostic
- If CB-NAAT is positive → start treatment and send sample for full drug susceptibility testing
- If CB-NAAT is negative but clinical suspicion remains → chest X-ray, repeat sputum, or culture
- Universal Drug Susceptibility Testing (UDST) — every confirmed TB patient should be tested for drug resistance
Where to get tested free: All District TB Centres (DTCs), designated microscopy centres, Community Health Centres (CHCs), Primary Health Centres (PHCs), and many government hospitals offer free TB testing. India now has over 4,700 CB-NAAT machines deployed across the country.
TB Treatment Under NTEP: Drug-Sensitive TB
If your TB is sensitive to first-line drugs (no drug resistance detected), you will receive a standardised regimen using Fixed Dose Combinations (FDCs) — single tablets containing multiple drugs in the right proportions for your weight.
The Standard 6-Month Regimen
Treatment is divided into two phases:
Intensive Phase (2 months / 56 doses)
- H — Isoniazid
- R — Rifampicin
- Z — Pyrazinamide
- E — Ethambutol
All four drugs are given daily as a single FDC tablet (dose adjusted by weight band).
Continuation Phase (4 months / 112 doses)
- H — Isoniazid
- R — Rifampicin
- E — Ethambutol
Pyrazinamide is stopped; the remaining three drugs continue daily.
Weight-Based Dosing
| Patient Weight | Intensive Phase (HRZE) | Continuation Phase (HRE) |
|---|---|---|
| 25-39 kg | 2 FDC tablets daily | 2 FDC tablets daily |
| 40-54 kg | 3 FDC tablets daily | 3 FDC tablets daily |
| 55-69 kg | 4 FDC tablets daily | 4 FDC tablets daily |
| ≥70 kg | 5 FDC tablets daily | 5 FDC tablets daily |
Key Treatment Rules
- Daily dosing — NTEP switched from thrice-weekly to daily dosing in 2017 for better outcomes
- Never miss doses — irregular treatment is the single biggest cause of drug resistance
- Take on an empty stomach — rifampicin is best absorbed on an empty stomach (at least 1 hour before or 2 hours after food)
- Complete the full 6 months — even if you feel better after 2-3 months, stopping early leads to relapse and drug resistance
- Pyridoxine (Vitamin B6) supplementation — often prescribed alongside to prevent isoniazid-induced neuropathy
Drug-Resistant TB: When Standard Treatment Fails
Drug-resistant TB (DR-TB) is a growing concern in India, with an estimated 1.19 lakh cases annually. If your TB bacteria are resistant to one or more first-line drugs, you will need a modified, longer treatment regimen.
Types of Drug Resistance
| Type | Definition | Estimated Cases in India |
|---|---|---|
| Mono-resistant TB | Resistant to any single first-line drug | Variable |
| MDR-TB (Multi-Drug Resistant) | Resistant to at least isoniazid AND rifampicin | ~1.19 lakh/year |
| Pre-XDR-TB | MDR-TB + resistance to any fluoroquinolone | Growing concern |
| XDR-TB (Extensively Drug Resistant) | MDR-TB + resistance to fluoroquinolone + bedaquiline or linezolid | Rare but serious |
The BPaLM Regimen — A Game-Changer
In 2024, India's Ministry of Health approved the BPaLM regimen for MDR-TB — a shorter, more effective treatment:
- B — Bedaquiline
- Pa — Pretomanid
- L — Linezolid
- M — Moxifloxacin
This regimen reduces treatment from 18-20 months down to 6-9 months with significantly better cure rates and fewer side effects. It represents one of the most important advances in TB treatment in decades.
Key point: DR-TB treatment must be managed by a specialist at a DR-TB centre. Never attempt to modify your treatment regimen on your own — always consult your treating physician.
Side Effects of TB Medications
TB drugs are powerful, and side effects are common. Knowing what to expect helps you stay on track:
Common Side Effects
| Drug | Common Side Effects | What to Do |
|---|---|---|
| Isoniazid (H) | Tingling/numbness in hands and feet (peripheral neuropathy), mild liver enzyme elevation | Take Vitamin B6 (pyridoxine); report numbness to doctor |
| Rifampicin (R) | Orange-red urine, tears, and sweat; nausea; drug interactions | Orange discolouration is harmless and expected; inform doctor of all other medications |
| Pyrazinamide (Z) | Joint pain (raised uric acid), nausea, liver toxicity | Stay hydrated; report severe joint pain |
| Ethambutol (E) | Visual disturbances (colour vision changes, blurred vision) | Report any vision changes immediately — this is the signal to stop ethambutol |
Red Flag Side Effects — See Your Doctor Immediately
- Jaundice (yellowing of eyes/skin) — suggests drug-induced liver injury
- Severe skin rash or itching
- Persistent vomiting preventing medication intake
- Visual disturbances (especially with ethambutol)
- Severe abdominal pain
- Easy bruising or bleeding
Your doctor will monitor your liver function (LFT) and uric acid levels during treatment to catch drug-related toxicity early. Upload your reports to MedicalVault to track these values over the treatment period.
Monitoring Your TB Treatment
Regular monitoring ensures treatment is working and catches complications early. Here is what to expect:
Standard Monitoring Schedule
| When | Tests | Purpose |
|---|---|---|
| At diagnosis | Sputum smear/culture, chest X-ray, CB-NAAT, LFT, CBC, blood sugar, HIV test | Baseline assessment |
| End of month 2 | Sputum smear/culture, LFT | Check conversion (sputum should turn negative) |
| End of month 3 | Sputum smear (if month 2 was positive) | Confirm conversion |
| End of month 5 | Sputum smear/culture | Near-completion check |
| End of month 6 | Sputum smear/culture, chest X-ray | Treatment completion and cure confirmation |
Key Markers to Track
- Sputum conversion — sputum turning negative (no TB bacteria detected) by month 2 is the strongest sign of treatment success
- ESR (Erythrocyte Sedimentation Rate) — elevated in 90-98% of active TB cases; a falling ESR during treatment supports progress
- Weight gain — steady weight recovery indicates improving nutrition and decreasing disease burden
- Chest X-ray improvement — gradual clearing of lung lesions over months
- Liver function tests — monitored to detect drug-induced hepatotoxicity
Use MedicalVault's trend analysis to visualise your sputum results, ESR, LFT, and weight changes over the 6-month treatment journey. Share reports with your treating doctor through the family sharing feature so they can track your progress remotely.
Free Government Support for TB Patients
India offers comprehensive free support for TB patients through NTEP. Here is what you are entitled to:
Free Diagnosis and Treatment
- All TB tests are free at government facilities — sputum microscopy, CB-NAAT, culture, DST, chest X-ray
- All TB medications are free — first-line FDCs for drug-sensitive TB and second-line drugs for DR-TB
- Available at District TB Centres, CHCs, PHCs, government hospitals, and identified private facilities
Nikshay Poshan Yojana — Nutritional Support
The government provides ₹1,000 per month (increased from ₹500 in November 2024) to every registered TB patient for the entire duration of treatment:
- For drug-sensitive TB (6 months): Total ₹6,000
- For drug-resistant TB (longer treatment): Proportionally more
- Money is transferred directly to the patient's Aadhaar-linked bank account via Direct Benefit Transfer (DBT)
- Since 2018, over ₹4,300 crore has been disbursed to 1.35 crore TB patients
How to register: Your treating doctor registers you on the Nikshay portal (India's national TB surveillance system). Once registered, payments are processed automatically.
Nikshay Mitra — Community Support
Under the Pradhan Mantri TB Mukt Bharat Abhiyaan, individuals, organisations, and corporates can "adopt" TB patients as Nikshay Mitras, providing additional nutritional, diagnostic, and vocational support.
Additional Entitlements
- Free HIV testing for all TB patients (TB-HIV co-infection is tested routinely)
- Free diabetes screening — diabetes increases TB risk significantly, and NTEP screens all TB patients for diabetes
- Contact tracing — household contacts of TB patients are screened free of charge
- Preventive therapy — eligible contacts receive free preventive treatment to stop latent TB from becoming active
TB and Nutrition: Why Diet Matters
Malnutrition is both a risk factor for TB and a consequence of it. India's high rates of undernutrition make this connection particularly important:
- Underweight individuals (BMI <18.5) have a 3-4 times higher risk of developing active TB
- Active TB causes further weight loss, creating a vicious cycle
- Adequate nutrition improves treatment outcomes and speeds recovery
Dietary Recommendations During TB Treatment
- High-protein foods — dal, paneer, eggs, chicken, fish, soya chunks, sprouts (aim for 1.2-1.5 g protein per kg body weight daily)
- Calorie-dense meals — add ghee to dal and roti, eat nuts and dry fruits as snacks
- Iron-rich foods — jaggery, green leafy vegetables (palak, methi), beetroot to combat anaemia which commonly accompanies TB
- Vitamin C-rich fruits — amla, guava, orange, lemon to boost iron absorption and immunity
- Avoid alcohol completely — alcohol worsens liver toxicity from TB drugs and weakens immunity
- Avoid tobacco — smoking damages lungs further and reduces treatment effectiveness
Preventing TB Transmission
If you or a family member is being treated for pulmonary TB, follow these precautions:
- Cough hygiene — cover mouth when coughing, use a handkerchief or mask
- Ventilation — keep rooms well-ventilated; open windows to allow fresh air circulation
- Sputum disposal — spit into a covered container; never spit on the ground
- Masks — the patient should wear a mask when around others, especially in the first 2 weeks of treatment (after which infectiousness drops significantly)
- BCG vaccination — ensure children receive the BCG vaccine at birth (part of India's Universal Immunisation Programme). BCG does not prevent TB infection but significantly reduces the risk of severe forms like TB meningitis in children
- Contact screening — all household contacts should be screened for TB symptoms and offered preventive therapy if eligible
Common Myths About TB in India
| Myth | Fact |
|---|---|
| TB is hereditary | TB is an infectious disease caused by bacteria, not genes. However, family members living together face higher exposure risk |
| TB only affects the lungs | While pulmonary TB is most common, TB can affect lymph nodes, spine, brain, kidneys, and virtually any organ |
| TB treatment needs expensive private hospitals | All TB treatment is free at government facilities under NTEP. Many private doctors also use NTEP-supplied drugs |
| You can stop medicines once you feel better | Incomplete treatment is the leading cause of drug resistance. Always complete the full course |
| TB patients must be isolated at home | After 2 weeks of proper treatment, infectiousness drops dramatically. Basic cough hygiene and ventilation are sufficient |
| Only poor people get TB | TB affects all socioeconomic groups. Diabetes, stress, overcrowding, and air pollution are risk factors across income levels |
| Ayurvedic/homeopathic remedies can cure TB | There is no scientific evidence that alternative therapies cure TB. Delaying proper treatment is dangerous and can lead to drug resistance and death |
When to See Your Doctor Urgently
During or after TB treatment, seek immediate medical attention if you notice:
- Coughing up blood (haemoptysis) — even small amounts
- Yellowing of eyes or skin — possible drug-induced liver injury
- High fever returning after initial improvement — could indicate treatment failure or a different infection
- Sudden vision changes — especially if taking ethambutol
- Severe breathlessness — may indicate pleural effusion or pneumothorax
- New symptoms in a different body part — could suggest extrapulmonary spread
- Persistent positive sputum after 3 months of treatment — raises concern for drug resistance
Key Takeaways
- TB is completely curable — with proper 6-month treatment under NTEP, cure rates exceed 85% for drug-sensitive TB. Never stop treatment early, even if you feel well
- All TB diagnosis and treatment is free at government facilities across India — from sputum tests and CB-NAAT to the full course of anti-TB medications
- CB-NAAT (GeneXpert) is now the preferred first test — it detects TB and rifampicin resistance in just 2 hours, available at over 4,700 centres nationwide
- Daily FDC tablets have replaced thrice-weekly dosing — the standard HRZE regimen for 2 months followed by HRE for 4 months is the current protocol for drug-sensitive TB
- The BPaLM regimen is transforming DR-TB treatment — reducing MDR-TB treatment from 18-20 months to 6-9 months with better outcomes
- Nikshay Poshan Yojana provides ₹1,000/month to every registered TB patient for nutritional support — ensure your doctor registers you on the Nikshay portal
- Track your treatment journey on MedicalVault — upload your sputum reports, ESR, LFT, and chest X-rays to visualise progress and share with your doctor through the family sharing feature